Hormone-replacement therapy and lobular cancers: new deals and old myths
2008
Luca Mariani, Claudio Robba, Giulia Moggio and Piero Sismondi Academic Department of Gynaecological Oncology, University of Turin Mauriziano Umberto I° Hospital of Turin & Institute for Cancer Research and Treatment of Candiolo, Turin, Italy “Several studies have reported that past and current users of combined hormone-replacement therapy are at a higher risk of developing invasive lobular carcinoma than invasive ductal–lobular mixed carcinoma.”
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
53
References
1
Citations
NaN
KQI